Cargando…
Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815183/ https://www.ncbi.nlm.nih.gov/pubmed/35120500 http://dx.doi.org/10.1186/s12943-021-01493-6 |
_version_ | 1784645229479985152 |
---|---|
author | Liu, Yudong Mao, Xia Ma, Zhaochen Chen, Wenjia Guo, Xiaodong Yu, Lingxiang Deng, Xinxin Jiang, Funeng Li, Taixian Lin, Na Zhang, Yanqiong |
author_facet | Liu, Yudong Mao, Xia Ma, Zhaochen Chen, Wenjia Guo, Xiaodong Yu, Lingxiang Deng, Xinxin Jiang, Funeng Li, Taixian Lin, Na Zhang, Yanqiong |
author_sort | Liu, Yudong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8815183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88151832022-02-07 Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy Liu, Yudong Mao, Xia Ma, Zhaochen Chen, Wenjia Guo, Xiaodong Yu, Lingxiang Deng, Xinxin Jiang, Funeng Li, Taixian Lin, Na Zhang, Yanqiong Mol Cancer Letter to the Editor BioMed Central 2022-02-04 /pmc/articles/PMC8815183/ /pubmed/35120500 http://dx.doi.org/10.1186/s12943-021-01493-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Liu, Yudong Mao, Xia Ma, Zhaochen Chen, Wenjia Guo, Xiaodong Yu, Lingxiang Deng, Xinxin Jiang, Funeng Li, Taixian Lin, Na Zhang, Yanqiong Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy |
title | Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy |
title_full | Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy |
title_fullStr | Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy |
title_full_unstemmed | Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy |
title_short | Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy |
title_sort | aberrant regulation of lncrna tug1-microrna-328-3p-srsf9 mrna axis in hepatocellular carcinoma: a promising target for prognosis and therapy |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815183/ https://www.ncbi.nlm.nih.gov/pubmed/35120500 http://dx.doi.org/10.1186/s12943-021-01493-6 |
work_keys_str_mv | AT liuyudong aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT maoxia aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT mazhaochen aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT chenwenjia aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT guoxiaodong aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT yulingxiang aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT dengxinxin aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT jiangfuneng aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT litaixian aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT linna aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy AT zhangyanqiong aberrantregulationoflncrnatug1microrna3283psrsf9mrnaaxisinhepatocellularcarcinomaapromisingtargetforprognosisandtherapy |